Cancer risk in immune-mediated inflammatory diseases (IMID)

@inproceedings{Beyaert2013CancerRI,
  title={Cancer risk in immune-mediated inflammatory diseases (IMID)},
  author={Rudi Beyaert and Laurent Beaugerie and Gert Van Assche and Li{\`e}ve Brochez and Jean-Christophe Renauld and M. Gabriel Viguier and Veronique F J Cocquyt and Guy H M Jerusalem and Jean-Pascal Machiels and Hans Prenen and Pierre L. Masson and Edouard J. Louis and Filip de Keyser},
  booktitle={Molecular Cancer},
  year={2013}
}
Inflammation and cancer have a profound yet ambiguous relationship. Inflammation - especially chronic inflammation - has protumorigenic effects, but inflammatory cells also mediate an immune response against the tumor and immunosuppression is known to increase the risk for certain tumors. This article reviews current literature on the role of inflammation in cancer and the cancer risk in immune-mediated inflammatory diseases (IMIDs). We discuss the effect on cancer risk of different drug… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 150 references

The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan

  • Chen Y-J, Wu C-Y, +4 authors Chang Y-T
  • J Am Acad Dermatol
  • 2011
Highly Influential
15 Excerpts

Similar Papers

Loading similar papers…